PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers

Although we know lncRNAs play a role in cancer, the identification of clinically relevant and functional lncRNAs is lacking. Here, the authors identify 633 prognostic markers, 570 S-phase cancer-associated lncRNAs, and show SCAT7 regulates FGF/FGFR and PI3K/AKT/MAPK pathways via interaction with hnR...

Full description

Bibliographic Details
Main Authors: Mohamad Moustafa Ali, Vijay Suresh Akhade, Subazini Thankaswamy Kosalai, Santhilal Subhash, Luisa Statello, Matthieu Meryet-Figuiere, Jonas Abrahamsson, Tanmoy Mondal, Chandrasekhar Kanduri
Format: Article
Language:English
Published: Nature Portfolio 2018-02-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-018-03265-1
_version_ 1818750529313964032
author Mohamad Moustafa Ali
Vijay Suresh Akhade
Subazini Thankaswamy Kosalai
Santhilal Subhash
Luisa Statello
Matthieu Meryet-Figuiere
Jonas Abrahamsson
Tanmoy Mondal
Chandrasekhar Kanduri
author_facet Mohamad Moustafa Ali
Vijay Suresh Akhade
Subazini Thankaswamy Kosalai
Santhilal Subhash
Luisa Statello
Matthieu Meryet-Figuiere
Jonas Abrahamsson
Tanmoy Mondal
Chandrasekhar Kanduri
author_sort Mohamad Moustafa Ali
collection DOAJ
description Although we know lncRNAs play a role in cancer, the identification of clinically relevant and functional lncRNAs is lacking. Here, the authors identify 633 prognostic markers, 570 S-phase cancer-associated lncRNAs, and show SCAT7 regulates FGF/FGFR and PI3K/AKT/MAPK pathways via interaction with hnRNPK/YBX1 complexes.
first_indexed 2024-12-18T04:21:07Z
format Article
id doaj.art-157be40b73b2441180be0273025f743a
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-18T04:21:07Z
publishDate 2018-02-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-157be40b73b2441180be0273025f743a2022-12-21T21:21:14ZengNature PortfolioNature Communications2041-17232018-02-019112010.1038/s41467-018-03265-1PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkersMohamad Moustafa Ali0Vijay Suresh Akhade1Subazini Thankaswamy Kosalai2Santhilal Subhash3Luisa Statello4Matthieu Meryet-Figuiere5Jonas Abrahamsson6Tanmoy Mondal7Chandrasekhar Kanduri8Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgDepartment of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of GothenburgDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgAlthough we know lncRNAs play a role in cancer, the identification of clinically relevant and functional lncRNAs is lacking. Here, the authors identify 633 prognostic markers, 570 S-phase cancer-associated lncRNAs, and show SCAT7 regulates FGF/FGFR and PI3K/AKT/MAPK pathways via interaction with hnRNPK/YBX1 complexes.https://doi.org/10.1038/s41467-018-03265-1
spellingShingle Mohamad Moustafa Ali
Vijay Suresh Akhade
Subazini Thankaswamy Kosalai
Santhilal Subhash
Luisa Statello
Matthieu Meryet-Figuiere
Jonas Abrahamsson
Tanmoy Mondal
Chandrasekhar Kanduri
PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
Nature Communications
title PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
title_full PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
title_fullStr PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
title_full_unstemmed PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
title_short PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
title_sort pan cancer analysis of s phase enriched lncrnas identifies oncogenic drivers and biomarkers
url https://doi.org/10.1038/s41467-018-03265-1
work_keys_str_mv AT mohamadmoustafaali pancanceranalysisofsphaseenrichedlncrnasidentifiesoncogenicdriversandbiomarkers
AT vijaysureshakhade pancanceranalysisofsphaseenrichedlncrnasidentifiesoncogenicdriversandbiomarkers
AT subazinithankaswamykosalai pancanceranalysisofsphaseenrichedlncrnasidentifiesoncogenicdriversandbiomarkers
AT santhilalsubhash pancanceranalysisofsphaseenrichedlncrnasidentifiesoncogenicdriversandbiomarkers
AT luisastatello pancanceranalysisofsphaseenrichedlncrnasidentifiesoncogenicdriversandbiomarkers
AT matthieumeryetfiguiere pancanceranalysisofsphaseenrichedlncrnasidentifiesoncogenicdriversandbiomarkers
AT jonasabrahamsson pancanceranalysisofsphaseenrichedlncrnasidentifiesoncogenicdriversandbiomarkers
AT tanmoymondal pancanceranalysisofsphaseenrichedlncrnasidentifiesoncogenicdriversandbiomarkers
AT chandrasekharkanduri pancanceranalysisofsphaseenrichedlncrnasidentifiesoncogenicdriversandbiomarkers